Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Latest, Q2 2026
10,767
Period ended Jun 30, 2026
Change on a year earlier
+7.7%
9,996 in Q2 2025
History
27 quarters
Since Q4 2008
Sources
24
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Other Current Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| Q2 2026 | Jun 30, 2026 | 10,767 | +7.7% | Form 10-Q (filed 2026-08-07) ↗ |
| Q1 2026 | Mar 31, 2026 | 10,624 | +14.4% | Form 10-Q (filed 2026-05-04) ↗ |
| Q4 2025 | Dec 31, 2025 | 10,518 | +20.8% | Form 10-K (filed 2026-02-24) ↗ |
| Q3 2025 | Sep 30, 2025 | 10,779 | +32.4% | Form 10-Q (filed 2025-11-05) ↗ |
| Q2 2025 | Jun 30, 2025 | 9,996 | +14.4% | Form 10-Q (filed 2025-08-05) ↗ |
| Q1 2025 | Mar 31, 2025 | 9,289 | +16.8% | Form 10-Q (filed 2025-05-02) ↗ |
| Q4 2024 | Dec 31, 2024 | 8,706 | +4.0% | Form 10-K (filed 2025-02-25) ↗ |
| Q3 2024 | Sep 30, 2024 | 8,143 | +22.3% | Form 10-Q (filed 2024-11-06) ↗ |
| Q2 2024 | Jun 30, 2024 | 8,740 | – | Form 10-Q (filed 2024-08-05) ↗ |
| Q1 2024 | Mar 31, 2024 | 7,950 | – | Form 10-Q (filed 2024-05-03) ↗ |
| Q4 2023 | Dec 31, 2023 | 8,368 | +16.7% | Form 10-K (filed 2024-02-26) ↗ |
| Q3 2023 | Sep 30, 2023 | 6,656 | – | Form 10-Q (filed 2023-11-03) ↗ |
| Q4 2022 | Dec 31, 2022 | 7,169 | +2.6% | Form 10-K (filed 2023-02-24) ↗ |
| Q4 2021 | Dec 31, 2021 | 6,987 | +49.5% | Form 10-K (filed 2022-02-25) ↗ |
| Q4 2020 | Dec 31, 2020 | 4,674 | +9.3% | Form 10-K (filed 2022-02-25) ↗ |
| Q4 2019 | Dec 31, 2019 | 4,277 | -5.0% | Form 10-K (filed 2020-02-26) ↗ |
| Q4 2018 | Dec 31, 2018 | 4,500 | +4.7% | Form 10-K (filed 2019-02-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 4,299 | -2.1% | Form 10-K (filed 2018-02-27) ↗ |
| Q4 2016 | Dec 31, 2016 | 4,389 | -14.6% | SEC Filing ↗ |
| Q4 2015 | Dec 31, 2015 | 5,140 | +9.6% | SEC Filing ↗ |
| Q4 2014 | Dec 31, 2014 | 4,689 | – | Form 10-K (filed 2016-02-26) ↗ |
| Q4 2010 | Dec 31, 2010 | 3,651 | -12.6% | Form 10-K (filed 2011-02-28) ↗ |
| Q3 2010 | Sep 30, 2010 | 3,570 | – | Form 10-Q (filed 2010-11-08) ↗ |
| Q2 2010 | Jun 30, 2010 | 3,791 | – | Form 10-Q (filed 2010-08-06) ↗ |
| Q1 2010 | Mar 31, 2010 | 4,145 | – | Form 10-Q (filed 2010-05-07) ↗ |
| Q4 2009 | Dec 31, 2009 | 4,177 | -51.6% | Form 10-K (filed 2011-02-28) ↗ |
| Q4 2008 | Dec 31, 2008 | 8,628 | – | Form 10-K (filed 2010-03-01) ↗ |
Cite this data
StockData. (2026). Merck Other Current Assets ($M) ($M), quarterly Q4 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_oca
See every metric in the Merck KPI table. Data updated Oct 26, 2026.